Physician profile
Cesar E Aranguri
NPI 1346297934
$3,434.65
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,394 · 2020: $72.84 · 2021: $171 · 2022: $48.08 · 2023: $390 · 2024: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,218.39 | 2019-2020 | |
| Medtronic, INC. | $643.22 | 2021-2024 | Corevalve Evolut R, Linq II, Micra |
| Biotronik INC. | $237.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.80 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.09 | 2023 | Lifevest |
| Grt US Holding, INC. | $28.53 | 2021 | |
| Braeburn INC. | $25.00 | 2024 | Brixadi |
| Edwards Lifesciences Corporation | $19.78 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Glaxosmithkline, LLC. | $16.10 | 2023 | Shingrix |
| Novartis Pharmaceuticals Corporation | $12.20 | 2022 | |
| Siemens Medical Solutions USA, INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Aranguri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.